Pfizer (PFE)

Retained Earnings

$112.09B

Quarterly · Period ending: · USD

PFE logo

PFE Retained Earnings

Latest reported$112.09B
PFE Quarterly Retained Earnings ($2.54B → $112.09B)
High-resolution chart · PNG

PFE retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
112,087,000,000
117,238,000,000
114,610,000,000
121,150,000,000
117,609,000,000
119,590,000,000
116,725,000,000
121,059,000,000
116,596,000,000
121,318,000,000
118,353,000,000
126,411,000,000
128,796,000,000
131,102,000,000
125,656,000,000
122,967,000,000
116,608,000,000
111,193,000,000
103,394,000,000
102,252,000,000
96,346,000,000
95,158,000,000
96,770,000,000
100,284,000,000
100,203,000,000
101,000,000,000
97,670,000,000
100,113,000,000
94,440,000,000
93,388,000,000
89,554,000,000
91,995,000,000
89,860,000,000
89,961,000,000
85,291,000,000
75,043,000,000
74,107,000,000
74,847,000,000
71,774,000,000
72,846,000,000
73,350,000,000
74,971,000,000
71,993,000,000
74,019,000,000
73,620,000,000
74,471,000,000
72,176,000,000
74,292,000,000
71,627,000,000
72,028,000,000
69,732,000,000
70,381,000,000
67,628,000,000
56,972,000,000
54,240,000,000
51,256,000,000
47,904,000,000
48,124,000,000
46,210,000,000
48,121,000,000
44,320,000,000
44,926,000,000
42,716,000,000
42,873,000,000
42,010,000,000
42,429,000,000
40,426,000,000
54,835,000,000
51,965,000,000
51,863,000,000
49,142,000,000
53,175,000,000
50,912,000,000
52,436,000,000
49,660,000,000
51,063,000,000
50,304,000,000
53,063,000,000
49,669,000,000
43,991,000,000
40,627,000,000
41,715,000,000
37,608,000,000
38,033,000,000
36,446,000,000
35,785,000,000
35,492,000,000
35,347,000,000
32,003,000,000
31,707,000,000
29,382,000,000
31,191,000,000
28,923,000,000
34,908,000,000
30,243,000,000
29,099,000,000
26,742,000,000
26,788,000,000
24,430,000,000
23,967,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.